MCT provides extensive clinical trials operations across Africa, the Middle East, Pakistan, and EAEU countries.
Why choose MCT?
Repeat Business
Audited Times by Clients
- Wide Patient Access – Extensive networks providing access to diverse patient populations
- Key Site Connections – Strong partnerships with top clinical sites for seamless study execution
- Broad Therapeutic Expertise – Proven experience across multiple therapeutic areas and study phases
- Unique Training Programs – Internal programs ensuring highly skilled and compliant teams
- Internal & External Audits – Rigorous audit processes maintaining high standards of GCP compliance
- Dedicated Teams – Local single point of contact and personalized project management
Why Conduct Clinical Trials in the Middle East, Africa, Pakistan & EAEU?
- High recruitment potential – Large, genetically diverse, and often treatment-naïve patient populations
- Underrepresented in global trials – This region represents 18% of the world’s population but only ~3% of clinical trials, offering access to valuable data
- Growing centers of excellence – Countries such as Saudi Arabia, UAE, Egypt, and Lebanon are rapidly developing world-class research centers
- Meaningful scientific and ethical impact – Inclusive, locally relevant research ensures ethical integrity and produces scientifically significant results
Quality
Internal
Audits
Audits
Training
Program
Program
Co-Monitoring
Visits
Visits
Independent Quality Department
Proprietary
SOP
SOP

